Description Incorporated and registered in Tianjin, China

Description Completed commissioning of pilot facility designed to meet the GMP

Description Filed CTA for MCV2 & MCV4

Description Pilot facility passed EMA's QP inspection;
Obtained MCV2 & MCV4 CTA approvals

Description Filed CTA for DTcP candidates;
Obtained CTA approval of Ad5-EBOV and initiated clinical trial

Description Completed Ad5-EBOV Phase II clinical trial in Sierra Leone;
Submitted CTA of PBPV

Description GENEVA (Reuters) - The World Health Organization has raised its assessment of the public health risk from Democratic Republic of Congos Ebola outbreak to very high at the national level, from high previously,

Description CHICAGO (Reuters) - The U.S. government is investing more than $170 million to help two new vaccines against the Ebola virus and two Ebola drugs complete the steps needed for approval from the Food and Drug Admini

Description Taipei Times | Most of the people infected with Ebola in the West Africa epidemic that began in 2014 got sick through contact with a small number of “superspreaders” with the disease, researchers said on Monday.

Description The 2014 Ebola pandemic offered many lessons but perhaps none more apparent than the need to shift responsibility for public health from nations to the cities within them.